Zobair M. Younossi
Impact in
- Hepatology top 0.01%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Liver Diseases and Immunity
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 541
- Liver Disease Diagnosis and Treatment 515
- Hepatitis B Virus Studies 58
- Hepatology 427
- Hepatitis C virus research 278
- Liver Disease and Transplantation 152
- Liver Diseases and Immunity 71
- Co-authors
- Linda Henry (144 shared papers)Maria Stepanova (244 shared papers)Arun J. Sanyal (35 shared papers)Aaron B. Koenig (10 shared papers)Yousef Fazel (6 shared papers)Dinan Abdelatif (4 shared papers)Kenneth Cusi (18 shared papers)Pegah Golabi (103 shared papers)
- Journals
- Journal of Hepatology (106 papers)Gastroenterology (78 papers)Hepatology (52 papers)Alimentary Pharmacology & Therapeutics (48 papers)Liver International (39 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Zobair M. Younossi
800 papers receiving 77.3k citations
Zobair M. Younossi's Hit Papers
Peers
Comparison fields: 5 of 179
- Hepatology 23.0k
- Epidemiology 55.5k
- Endocrinology, Diabetes and Metabolism 16.0k
- Pathology and Forensic Medicine 5.8k
- Physiology 5.7k
Countries citing papers authored by Zobair M. Younossi
This map shows the geographic impact of Zobair M. Younossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zobair M. Younossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zobair M. Younossi more than expected).
Fields of papers citing papers by Zobair M. Younossi
This network shows the impact of papers produced by Zobair M. Younossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zobair M. Younossi. The network helps show where Zobair M. Younossi may publish in the future.
Co-authors
The 25 scholars most cited alongside Zobair M. Younossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 835 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes Hit paper breakdown → | 2015 | 7913 |
| 2 | The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases Hit paper breakdown → | 2017 | 5284 |
| 3 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Hit paper breakdown → | 2017 | 3960 |
| 4 | The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hit paper breakdown → | 2012 | 3064 |
| 5 | Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆ Hit paper breakdown → | 1999 | 2694 |
| 6 | Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults Hit paper breakdown → | 2011 | 2465 |
| 7 | The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review Hit paper breakdown → | 2023 | 1772 |
| 8 | Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease Hit paper breakdown → | 2017 | 1734 |
| 9 | The utility of radiological imaging in nonalcoholic fatty liver disease Hit paper breakdown → | 2002 | 1640 |
| 10 | Non-alcoholic fatty liver disease – A global public health perspective Hit paper breakdown → | 2018 | 1581 |
| 11 | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis Hit paper breakdown → | 2019 | 1565 |
| 12 | The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Hit paper breakdown → | 2012 | 1413 |
| 13 | Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Hit paper breakdown → | 2018 | 1388 |
| 14 | Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis Hit paper breakdown → | 2017 | 1385 |
| 15 | The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe Hit paper breakdown → | 2016 | 928 |
| 16 | Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008 Hit paper breakdown → | 2011 | 866 |
| 17 | Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Hit paper breakdown → | 2020 | 702 |
| 18 | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Hit paper breakdown → | 2022 | 643 |
| 19 | Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates Hit paper breakdown → | 2018 | 612 |
| 20 | Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 Hit paper breakdown → | 2015 | 599 |
About Zobair M. Younossi
Zobair M. Younossi is a scholar working on Epidemiology, Hepatology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Surgery, having authored 835 papers that have together received 78.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (515 papers), Hepatitis C virus research (278 papers), Liver Disease and Transplantation (152 papers), Diet, Metabolism, and Disease (76 papers), Liver Diseases and Immunity (71 papers), Hepatitis B Virus Studies (58 papers), Alcohol Consumption and Health Effects (55 papers) and Systemic Lupus Erythematosus Research (32 papers). The work is most often cited by research in Hepatology (23.0k citations), Epidemiology (55.5k citations), Endocrinology, Diabetes and Metabolism (16.0k citations), Pathology and Forensic Medicine (5.8k citations) and Physiology (5.7k citations). Zobair M. Younossi has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Linda Henry, Maria Stepanova, Arun J. Sanyal, Aaron B. Koenig, Yousef Fazel, Dinan Abdelatif, Kenneth Cusi, Pegah Golabi, Elizabeth M. Brunt and Michael Charlton. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Alimentary Pharmacology & Therapeutics and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.